Skip to content
value.today
TELA Bio, Inc. logo

TELA Bio, Inc.

Total raised
$103 M
7 rounds on record
Latest round
$11 M
Jun 2019
First round on record
Dec 2012
Today
Went public
See the company page

TELA Bio, Inc. is listed today as TELA Bio, Inc.: market value, financials and filings are on its company page.

Funding rounds

7 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of TELA Bio, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Jun 2019$11 MNo. 7$10 to $50 million

TELA Bio, Inc.: Raise no. 7, Jun 2019

Investors in this round

15 investors had bought by the notice of Jul 10, 2019: 15 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 9 investors are named for TELA Bio, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$11 M of $20 M offered; $9 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Antony Koblish · Executive Officer, Director
  • Francis Conway · Executive Officer
  • Maarten Persenaire · Executive Officer
  • Nora J. Brennan · Executive Officer
  • Adele Oliva · Director
  • Ashley Friedman · Director
  • Kurt Azarbarzin · Director
  • Matt Zuga · Director
  • Ronald J. Ellis, Jr. · Director
  • Vince Burgess · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Antony Koblish, President and CEO. Source: SEC Form D, newest notice filed Jul 10, 2019. Read the notice at the SEC.

equitySEC
Nov 2018$2 MNo. 6$2 to $10 million

TELA Bio, Inc.: Raise no. 6, Nov 2018

Investors in this round

8 investors had bought by the notice of Dec 4, 2018: 8 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 9 investors are named for TELA Bio, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$2 M of $4 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Antony Koblish · Executive Officer, Director
  • Francis Conway · Executive Officer
  • Maarten Persenaire · Executive Officer
  • Adele Oliva · Director
  • Ashley Friedman · Director
  • Kevin Rakin · Director
  • Kurt Ararbarzin · Director
  • Ronald J. Ellis, Jr. · Director
  • Vince Burgess · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Antony Koblish, President and CEO. Source: SEC Form D, newest notice filed Dec 4, 2018. Read the notice at the SEC.

equitySEC
Oct 2017$15 MNo. 5$10 to $50 million

TELA Bio, Inc.: Raise no. 5, Oct 2017

Investors in this round

1 investor had bought by the notice of Nov 2, 2017: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 9 investors are named for TELA Bio, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$15 M of $25 M offered; $10 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Antony Koblish · Executive Officer, Director
  • Christopher Smith · Executive Officer
  • Francis Conway · Executive Officer
  • Maarten Persenaire · Executive Officer
  • Adele Oliva · Director
  • Ashley Friedman · Director
  • Kevin Rakin · Director
  • Paul Touhey · Director
  • Vince Burgess · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Antony Koblish, President and CEO. Source: SEC Form D, newest notice filed Nov 2, 2017. Read the notice at the SEC.

equitySEC
Jan 2017$7 MNo. 4$2 to $10 million

TELA Bio, Inc.: Raise no. 4, Jan 2017

Investors in this round

16 investors had bought by the notice of Jan 27, 2017: 16 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 9 investors are named for TELA Bio, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$7 M of $8 M offered; $0 M still to sell
Smallest investment taken
$50,000
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Antony Koblish · Executive Officer, Director
  • Francis Conway · Executive Officer
  • Maarten Persenaire · Executive Officer
  • Adele Oliva · Director
  • Ashley Freidman · Director
  • Kevin Rakin · Director
  • Paul Touhey · Director
  • Vince Burgass · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Antony Koblish, President and CEO. Source: SEC Form D, newest notice filed Jan 27, 2017. Read the notice at the SEC.

equitySEC
Oct 2014$45 MNo. 3$10 to $50 million

TELA Bio, Inc.: Raise no. 3, Oct 2014

Investors in this round

29 investors had bought by the notice of Oct 8, 2014: 29 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 9 investors are named for TELA Bio, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$45 M of $45 M offered
Smallest investment taken
$20,000
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Christine Arasin · Executive Officer
  • Francis Conway · Executive Officer
  • Maarten Persenaire · Executive Officer
  • Adele C. Oliva · Director
  • Antony Koblish · Director
  • Ashley C. Friedman · Director
  • Kevin C. Rakin · Director
  • Paul C. Touhey · Director
  • Vince Burgess · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Antony Koblish, President and CEO. Source: SEC Form D, newest notice filed Oct 8, 2014. Read the notice at the SEC.

equitySEC
Aug 2013$6 MNo. 2$2 to $10 million

TELA Bio, Inc.: Raise no. 2, Aug 2013

Investors in this round

16 investors had bought by the notice of Aug 14, 2013: 16 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 9 investors are named for TELA Bio, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$6 M of $6 M offered
Smallest investment taken
$11,689
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Antony Koblish · Executive Officer, Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Antony Koblish, President and CEO. Source: SEC Form D, newest notice filed Aug 14, 2013. Read the notice at the SEC.

equitySEC
Dec 2012$16 MNo. 1$10 to $50 million

TELA Bio, Inc.: Raise no. 1, Dec 2012

Investors in this round

15 investors had bought by the notice of Dec 6, 2012: 15 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 9 investors are named for TELA Bio, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$16 M of $16 M offered
Smallest investment taken
$25,000
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Antony Koblish · Executive Officer · President

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Includes cash proceeds and proceeds of indebtedness of the Issuer converted in the offering.”

Signed by Antony Koblish, President. Source: SEC Form D, newest notice filed Dec 6, 2012. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • As the listed company TELA Bio, Inc., its revenue in fiscal 2025 came from these business segments: Single reportable segment $80.28 million (100%).

    Annual report (SEC XBRL) · Dec 2025

  • TELA Bio, Inc. chose not to state its revenue in its newest notice of a funding round (Jul 2019).

    SEC Form D · Jul 2019

  • The industry group it chose in its notices: Other Technology.

    SEC Form D · Jul 2019

Products and services#

No products or services of TELA Bio, Inc. are on record.

Investors#

9 named in official filings. Open an investor to see everything it has backed.

Investors in TELA Bio, Inc.
InvestorKindAmountRoundRoleSource
Antony KoblishPersonnot statednot statedHeld Series B preferred stock, director (Form 3, 2019)SEC Form 3
Ellis Skott GreenhalghPersonnot statednot statedHeld Series A and B preferred stock (Form 3, 2019)SEC Form 3
Maarten PersenairePersonnot statednot statedHeld Series A and B preferred stock (Form 3, 2019)SEC Form 3
Nora BrennanPersonnot statednot statedHeld Series B preferred stock (Form 3, 2019)SEC Form 3
Orbimed Advisors LLCFund or asset managernot statednot statedHeld Series A and B preferred stock, 10% owner (Form 3, 2019)SEC Form 3
OrbiMed Capital GP IV LLCFund or asset managernot statednot statedHeld Series A and B preferred stock, 10% owner (Form 3, 2019)SEC Form 3
Pacira BioSciences, Inc.Companynot statednot statedHeld Series B preferred stock, 10% owner (Form 3, 2019)SEC Form 3
Quaker BioVentures Capital II, L.P.Venture capitalnot statednot statedHeld Series A and B preferred stock, 10% owner (Form 3, 2019)SEC Form 3
Quaker BioVentures II LPVenture capitalnot statednot statedHeld Series A and B preferred stock, 10% owner (Form 3, 2019)SEC Form 3

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 7 rounds above had up to 29 investors.

Largest shareholders today

Institutions holding TELA Bio, Inc. shares, as of Sep 30, 2026.

Source: SEC Form 13F holdings reports · as of Sep 30, 2026. Value held and share of the company. All holders are on the company page.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by TELA Bio, Inc.
NameRoleNamed in
Antony KoblishExecutive officerJul 2019
Francis ConwayExecutive officerJul 2019
Maarten PersenaireExecutive officerJul 2019
Nora J. BrennanExecutive officerJul 2019
Christopher SmithExecutive officerNov 2017
Christine ArasinExecutive officerOct 2014
Adele OlivaDirectorJul 2019
Antony KoblishDirectorJul 2019
Ashley FriedmanDirectorJul 2019
Kurt AzarbarzinDirectorJul 2019
Matt ZugaDirectorJul 2019
Ronald J. Ellis, Jr.DirectorJul 2019
Vince BurgessDirectorJul 2019
Kevin RakinDirectorDec 2018
Kurt ArarbarzinDirectorDec 2018
Paul TouheyDirectorNov 2017
Ashley FreidmanDirectorJan 2017
Vince BurgassDirectorJan 2017
Adele C. OlivaDirectorOct 2014
Ashley C. FriedmanDirectorOct 2014
Kevin C. RakinDirectorOct 2014
Paul C. TouheyDirectorOct 2014

Went public since 2019. Its SEC number is that of a company listed on a stock exchange.